Table 2 Patient characteristics of claims dataset (age, gender, observation days in the first year after index date) in overall study population and different subgroups.

From: The economic burden of Myasthenia gravis from the patient´s perspective and reflected in German claims data

 

All incident1

No MG-related treatment

Standard treatment

Intensified treatment

SMD2

EOMG

LOMG

SMD3

n

775

229

447

99

 

120

655

 

Age in years at index date4, mean (SD)

66.9 (16.6)

65.4 (18.2)

66.5 (16.0)

72.1 (13.7)

0.38

36.7 (9.2)

72.4 (10.6)

3.60

Gender n (%)

 Female

383 (49.4)

137 (59.8)

204 (45.6)

42 (42.4)

1.08

71 (59.2)

312 (47.6)

0.23

 Male

392 (50.6)

92 (40.2)

243 (54.4)

57 (57.6)

 

49 (40.8)

343 (52.4)

 
  1. 1The cohort of incident MG patients included all patients who had received at least one inpatient and/or two confirmed outpatient diagnoses of MG (outpatient diagnoses in two different quarters; ICD-10 G70.0) in the period between 01/01/2015 and 31/12/2019, had furthermore a 12-months period without any MG diagnoses prior to the index date, and were continuously insured by the sickness fund 12 months before index date.
  2. 2Comparing standard and intensified treatment.
  3. 3Comparing EOMG and LOMG.
  4. 4Index date = first diagnosis reported in claims data.
Back to article page